跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRAN ETEXILATO TEVA 150 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRAN ETEXILATO TEVA 150 MG CAPSULAS DURAS EFG
Approved
STANDARD
DABIGATRAN ETEXILATO TEVA 150 MG CAPSULAS DURAS EFG
Teva Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 5, 2024
Approval ID
7de248c533f4a366
Company
Teva Gmbh
Type
Standard
Approval Details
Approval Id
7de248c533f4a366
Drug Cima Aemps Name
DABIGATRAN ETEXILATO TEVA 150 MG CAPSULAS DURAS EFG
Register Number
1231769020
Holder Company Name
Teva Gmbh
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-gmbh
Authorization Date
2024-11-05
Dosage Form
CÁPSULA DURA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Teva Gmbh
Company Detail Path
/organization/teva-gmbh
Company Information
Pharmaceutical Company Name
Teva GmbH
Country Name
Germany
Website
http://www.teva.de
Active Ingredients
DABIGATRAN ETEXILATO MESILATO
172,95 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 5, 2024
Approval ID
7de248c533f4a366
Type
Standard
Back to CIMA-AEMPS Approvals
